Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone
2. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside
3. 5-iodo-2-pyrimidinone-2'-deoxyribose
4. Ipdr
1. 93265-81-7
2. Ipdr
3. 5-iodo-2-pyrimidinone-2'-deoxyribose
4. Ipd-r
5. 3hx21a3sqf
6. 1-(2-deoxy-beta-ribofuranosyl)-5-iodo-2-pyrimidinone
7. Nsc-726188
8. 2(1h)-pyrimidinone, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-iodo-
9. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidin-2(1h)-one
10. Ropidoxuridine [usan]
11. Unii-3hx21a3sqf
12. Ropidoxuridine (inn/usan)
13. Ropidoxuridine [usan:inn]
14. 5-iodo-2-pyrimidinone 2' Deoxyribonucleoside
15. Ropidoxuridine [inn]
16. Schembl8602575
17. Chembl2103821
18. Dtxsid00239353
19. Zinc6091380
20. 5-iodo-2-pyrimidinone-2-deoxyribose
21. Db06485
22. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one
23. Hy-13742
24. Cs-0007768
25. D08992
26. D96122
27. 265i817
28. A901121
29. Q27257237
30. 5-iodo-1-(2-deoxy-beta-d-ribofuranosyl)pyrimidin-2(1h)-one
31. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodopyrimidin-2(1h)-one
32. 2(1h)-pyrimidinone, 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-iodo-
| Molecular Weight | 338.10 g/mol |
|---|---|
| Molecular Formula | C9H11IN2O4 |
| XLogP3 | -0.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 337.97635 g/mol |
| Monoisotopic Mass | 337.97635 g/mol |
| Topological Polar Surface Area | 82.4 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 357 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in cancer/tumors (unspecified).
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ropidoxuridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ropidoxuridine, including repackagers and relabelers. The FDA regulates Ropidoxuridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ropidoxuridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ropidoxuridine supplier is an individual or a company that provides Ropidoxuridine active pharmaceutical ingredient (API) or Ropidoxuridine finished formulations upon request. The Ropidoxuridine suppliers may include Ropidoxuridine API manufacturers, exporters, distributors and traders.
Ropidoxuridine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ropidoxuridine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ropidoxuridine GMP manufacturer or Ropidoxuridine GMP API supplier for your needs.
A Ropidoxuridine CoA (Certificate of Analysis) is a formal document that attests to Ropidoxuridine's compliance with Ropidoxuridine specifications and serves as a tool for batch-level quality control.
Ropidoxuridine CoA mostly includes findings from lab analyses of a specific batch. For each Ropidoxuridine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ropidoxuridine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ropidoxuridine EP), Ropidoxuridine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ropidoxuridine USP).
LOOKING FOR A SUPPLIER?
